These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites]. Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571 [TBL] [Abstract][Full Text] [Related]
5. [The absence of tolerance and withdrawal syndrome after the treatment with the new L-tryptophane-containing dipeptide anxiolytic GB-115]. Kolik LG; Garibova TL; Litvinova SA; Kuznetsova AL; Kapitsa IG; Kadnikov IA; Konstantinopol'skiĭ MA; Gudasheva TA; Voronina TA; Seredenin SB Vestn Ross Akad Med Nauk; 2011; (7):37-42. PubMed ID: 21899090 [TBL] [Abstract][Full Text] [Related]
6. Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity. Smrdel P; Grabnar I; Locatelli I; Cerne M; Andrensek S; Kovacic N; Kristl A; Bogataj M; Urleb U; Mrhar A Drug Dev Ind Pharm; 2009 Nov; 35(11):1293-304. PubMed ID: 19832629 [TBL] [Abstract][Full Text] [Related]
8. Experimental study of antinociceptive potency of dipeptide GB-115 during chemical and thermal stimulation. Kolik LG; Zhukov VN; Gudasheva TA; Seredenin SB Bull Exp Biol Med; 2012 Aug; 153(4):468-71. PubMed ID: 22977846 [TBL] [Abstract][Full Text] [Related]
9. [The study of biologically active conformation of cholecystokinin-4 dipeptide analog GB-115]. Gudasheva TA; Lezina VP; Kir'ianova EP; Deeva OA; Kolik LG; Seredenin SB Bioorg Khim; 2013; 39(3):293-302. PubMed ID: 24397028 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study of antidepressant effects of GB-115 dipeptide]. Kolik LG Eksp Klin Farmakol; 2011; 74(1):3-5. PubMed ID: 21476266 [TBL] [Abstract][Full Text] [Related]
11. The effect of dipeptide structure on dipeptide and amino acid clearance in rats. Kee AJ; Smith RC; Gross AS; Madsen DC; Rowe B Metabolism; 1994 Nov; 43(11):1373-8. PubMed ID: 7968592 [TBL] [Abstract][Full Text] [Related]
12. [Absolute bioavailability of ginkgolide compounds in rats]. Si HH; Geng T; Sun XP; Zhao J; Xue J Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2882-6. PubMed ID: 26666044 [TBL] [Abstract][Full Text] [Related]
14. Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115. Kolik LG; Gudasheva TA; Seredenin SB Bull Exp Biol Med; 2012 Oct; 153(6):851-4. PubMed ID: 23113301 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration. Boiko SS; Ostrovskaya RU; Zherdev VP; Korotkov SA; Gudasheva TA; Voronina TA; Seredenin SB Bull Exp Biol Med; 2000 Apr; 129(4):359-61. PubMed ID: 10977920 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice. Walder P; Buchar E; Machková Z; Vrba T; Flegel M; Janků I; Masek K Immunopharmacol Immunotoxicol; 1991; 13(1-2):101-19. PubMed ID: 1770213 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever. Klassen P; Mazariegos M; Solomons NW; Fürst P J Nutr; 2000 Feb; 130(2):177-82. PubMed ID: 10720166 [TBL] [Abstract][Full Text] [Related]